Nurexone Biologic Inc
(NRX.VN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2021 | |
| Assets | |
| Current Assets | |
| Cash & Cash Equivalents | 2,214 |
| Receivables | 517 |
| Other current assets | 19 |
| TOTAL | $2,836 |
| Non-Current Assets | |
| TOTAL | $0 |
| Total Assets | $2,836 |
| Liabilities | |
| Current Liabilities | |
| Short Term Debt | 1,043 |
| Accrued Expenses | 183 |
| Other current liabilities | 242 |
| TOTAL | $1,631 |
| Non-Current Liabilities | |
| Other Non-Current Liabilities | 28 |
| TOTAL | $28 |
| Total Liabilities | $1,659 |
| Shareholders' Equity | |
| Retained earnings | -2,249 |
| Other shareholders' equity | 169 |
| TOTAL | $1,177 |
| Total Liabilities And Equity | $2,836 |